AKT1 and glioma: Consequently, TRIM24 promotes phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha (PIK3CA) expression and AKT phosphorylation, leading to the activation of PI3K/AKT signaling, hence enhancing glioma cell proliferation and tumorigenesis [63].